Status
Conditions
Treatments
About
This trial aims to evaluate the effectiveness of a guideline-based decision support system for hypertension management by physicians at primary health care (PHC) centers in China in order to improve the delivery of appropriate treatment and blood pressure (BP) control for hypertensive individuals.
Full description
The LIGHT trial aims to assess the effectiveness of decision support system (DSS) for hypertension treatment in cluster clinics. At each stage, the main randomization will occur at the PHC center level. During the first 3 months (baseline period), the physicians at all sites will use an electronic data collection system to collect information about the individuals who attend the clinic. After site randomization, physicians at control sites will continue to deliver usual care, and physicians at intervention sites will receive training and support on the use of the DSS. And the DSS will recommend antihypertensive medications according to the assigned protocol. All individuals will be asked to attend the clinic at least once every 3 months.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria for Sites:
At least one drug available from each of the four classes of recommended antihypertensive drugs are provided at clinic:
Has an outpatient clinic for hypertension treatment and staff willing to take part in the study
Electronic data collection system is routinely used at clinic for hypertension management
At least 100 individuals with hypertension can attend the clinic every 3 months.
Inclusion Criteria for Visits:
Inclusion Criteria for Participants:
Exclusion Criteria for participants:
Primary purpose
Allocation
Interventional model
Masking
10,000 participants in 2 patient groups
Loading...
Central trial contact
Harlan M Krumholz, MD, SM; Xin Zheng, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal